Connection
Matthew Ellis to Thymidine Kinase
This is a "connection" page, showing publications Matthew Ellis has written about Thymidine Kinase.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.136 |
|
|
|
-
Bagegni N, Thomas S, Liu N, Luo J, Hoog J, Northfelt DW, Goetz MP, Forero A, Bergqvist M, Karen J, Neumüller M, Suh EM, Guo Z, Vij K, Sanati S, Ellis M, Ma CX. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib. Breast Cancer Res. 2017 Nov 21; 19(1):123.
Score: 0.136